New medication strategies for comorbid substance use and bipolar affective disorders
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 56 (10) , 771-777
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (DA12762, K05-DA0454, P50-DA04060)
- U.S. Department of Veterans Affairs
- Patrick and Catherine Weldon Donaghue Medical Research Foundation (DF #00–202)
This publication has 84 references indexed in Scilit:
- Gender Differences in Prevalence, Risk, and Clinical Correlates of Alcoholism Comorbidity in Bipolar DisorderAmerican Journal of Psychiatry, 2003
- Use of System-Wide Outcomes Monitoring Data to Compare the Effectiveness of Atypical Neuroleptic MedicationsAmerican Journal of Psychiatry, 2003
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002
- A pilot, open clinical study of depakote in the treatment of cocaine abuseHuman Psychopharmacology: Clinical and Experimental, 2001
- Update on Anticonvulsants for the Treatment of Alcohol WithdrawalThe American Journal on Addictions, 2001
- Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication HypothesisNeuropsychopharmacology, 1998
- Pharmacotherapy of Schizophrenia Patients With Comorbid Substance AbuseSchizophrenia Bulletin, 1997
- Enhanced Neurobehavioral Effects of Cocaine With Chronic Neuroleptic Exposure in RatsSchizophrenia Bulletin, 1997
- Substance Abuse and Schizophrenia: Editors' IntroductionSchizophrenia Bulletin, 1997
- Complex and rapid-cycling in bipolar children and adolescents: a preliminary studyJournal of Affective Disorders, 1995